Life-threatening hypophosphataemia secondary to zoledronic acid implementation in a middle-age patient who presented with advanced osteolysis in the course of multiple myeloma.

Endokrynol Pol

Department of Internal Medicine and Endocrinology, University Clinical Centre, Medical University of Warsaw, Warsaw, Poland.

Published: November 2020

Not required for Clinical Vignette.

Download full-text PDF	Source
http://dx.doi.org/10.5603/EP.a2019.0048	DOI Listing

Publication Analysis

life-threatening hypophosphataemia

hypophosphataemia secondary

secondary zoledronic

zoledronic acid

acid implementation

implementation middle-age

middle-age patient

patient presented

presented advanced

advanced osteolysis

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!